Investigators performing studies in patients with inflammatory bowel disease and obesity with type 2 diabetes implied that the IgA-coating of proinflammatory bacterial strains contributed to disease pathogenesis. This evidence concerns the gene CD79A and type 2 diabetes mellitus.